We are live on ! Find out more
LLY icon

Eli Lilly

1,118 hedge funds and large institutions have $61B invested in Eli Lilly in 2015 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 379 increasing their positions, 463 reducing their positions, and 75 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more call options, than puts

Call options by funds: $458M | Put options by funds: $261M

23% more funds holding in top 10

Funds holding in top 10: 3543 (+8)

5% more capital invested

Capital invested by funds: $58B → $61B (+$3.09B)

1% more first-time investments, than exits

New positions opened: 76 | Existing positions closed: 75

0.13% more ownership

Funds ownership: 75.64%75.78% (+0.13%)

1% less funds holding

Funds holding: 1,1301,118 (-12)

18% less repeat investments, than reductions

Existing positions increased: 379 | Existing positions reduced: 463

Holders
1,118
Holders Change
-12
Holders Change %
-1.06%
% of All Funds
29.78%
Holding in Top 10
43
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+22.86%
% of All Funds
1.15%
New
76
Increased
379
Reduced
463
Closed
75
Calls
$458M
Puts
$261M
Net Calls
+$197M
Net Calls Change
+$332M
Name Holding Trade Value Shares
Change
Change in
Stake
GCP
426
GSA Capital Partners
United Kingdom
$3.26M -$1.25M -17,519 -28%
VAM
427
Visium Asset Management
New York
$3.25M +$1.95M +27,368 +157%
CCMINC
428
Cardinal Capital Management Inc (North Carolina)
North Carolina
$3.22M -$15.7K -221 -0.5%
Northwestern Mutual Wealth Management
429
Northwestern Mutual Wealth Management
Wisconsin
$3.2M -$90.6K -1,272 -3%
CIM
430
Calvert Investment Management
Maryland
$3.18M +$341K +4,795 +12%
BCM
431
Brookstone Capital Management
Illinois
$3.17M +$807K +11,335 +35%
SI
432
Stephens Inc
Arkansas
$3.15M +$119K +1,667 +4%
TCT
433
TIAA CREF Trust
Missouri
$3.13M +$78.2K +1,098 +3%
WRM
434
Westport Resources Management
Connecticut
$3.12M -$139K -1,950 -4%
MCM
435
Maryland Capital Management
Maryland
$3.11M +$102K +1,435 +3%
RIG
436
Roosevelt Investment Group
New York
$3.09M -$78.9K -1,108 -3%
WDA
437
Wendell David Associates
New Hampshire
$3.05M
SFP
438
Santa Fe Partners
New Mexico
$3.04M +$2.71M +38,113 +1,038%
CIA
439
Capital Investment Advisors
Georgia
$3.03M +$24.7K +347 +0.8%
PFPT
440
Pinnacle Financial Partners (Tennessee)
Tennessee
$3.02M +$331K +4,649 +13%
SFT
441
Simmons First Trust
Arkansas
$3.02M +$492K +6,913 +20%
FAM
442
Fred Alger Management
New York
$3.01M +$4.41K +62 +0.1%
Connor, Clark & Lunn Investment Management (CC&L)
443
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.99M -$128K -1,800 -4%
FMBTD
444
First Midwest Bank Trust Division
Illinois
$2.98M -$63.8K -896 -2%
APFBOT
445
Amica Pension Fund Board of Trustees
Rhode Island
$2.98M
DA
446
Dunvegan Associates
California
$2.92M -$58.9K -827 -2%
TMAM
447
Tokio Marine Asset Management
Japan
$2.9M -$416K -5,838 -13%
TIA
448
Trust Investment Advisors
Indiana
$2.88M -$28.5K -400 -1%
Mackenzie Financial
449
Mackenzie Financial
Ontario, Canada
$2.87M +$288K +4,049 +11%
CFN
450
Cordasco Financial Network
Florida
$2.85M -$129K -1,812 -4%

LLY Hedge Fund Activity: Q1 2015 in Review

1,118 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q1 2015, worth a combined $61B — up 5.3% from $58B a quarter earlier.

Buyers outnumbered sellers: 76 funds opened new LLY positions and 75 closed out — a net gain of 1 holder — while 379 added to existing stakes and 463 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $352M. The largest seller was T. Rowe Price Associates, cutting an estimated $254M.

  • 1,118 institutional investors held Eli Lilly (LLY) as of Q1 2015, down from 1,130 in Q4 2014.
  • Funds reported $61B of Eli Lilly stock for Q1 2015, up 5.3% quarter-over-quarter.
  • 76 funds opened new Eli Lilly positions in Q1 2015 and 75 closed out, a net change of +1 holder.
  • The largest Eli Lilly buyer in Q1 2015 was Janus Henderson Investors US, an estimated $352M added.
  • The largest Eli Lilly seller in Q1 2015 was T. Rowe Price Associates, an estimated $254M sold.

Based on aggregated 13F filings for Q1 2015.